Literature DB >> 33261718

Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.

Floriane Gallais, Aurélie Velay, Charlotte Nazon, Marie-Josée Wendling, Marialuisa Partisani, Jean Sibilia, Sophie Candon, Samira Fafi-Kremer.   

Abstract

We investigated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies and T-cell responses against SARS-CoV-2 and human coronavirus (HCoV) 229E and OC43 in 11 SARS-CoV-2 serodiscordant couples in Strausbourg, France, in which 1 partner had evidence of mild coronavirus disease (COVID-19) and in 10 unexposed healthy controls. Patients with confirmed COVID-19 were considered index patients and their partners close contacts. All index patients displayed positive SARS-CoV-2-specific antibody and T-cell responses that lasted up to 102 days after symptom onset. All contacts remained seronegative for SARS-CoV-2; however, 6 reported COVID-19 symptoms within a median of 7 days after their partners, and 4 of those showed a positive SARS-CoV-2-specific T-cell response against 3 or 4 SARS-CoV-2 antigens that lasted up to 93 days after symptom onset. The 11 couples and controls displayed positive T-cell responses against HCoV-229E or HCoV-OC43. These data suggest that exposure to SARS-CoV-2 can induce virus-specific T-cell responses without seroconversion.

Entities:  

Keywords:  COVID-19; IgA; IgG; IgM; RT-PCR; SARS-CoV-2; antibodies; coronavirus disease; coronavirus symptoms; household exposure; interferon; intrafamilial contacts; serologic testing; severe acute respiratory syndrome coronavirus 2; viral-specific T-cell response

Year:  2020        PMID: 33261718     DOI: 10.3201/eid2701.203611

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  66 in total

1.  Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.

Authors:  Alexey A Komissarov; Inna V Dolzhikova; Grigory A Efimov; Denis Y Logunov; Olga Mityaeva; Ivan A Molodtsov; Nelli B Naigovzina; Iuliia O Peshkova; Dmitry V Shcheblyakov; Pavel Volchkov; Alexander L Gintsburg; Elena Vasilieva
Journal:  J Immunol       Date:  2022-01-31       Impact factor: 5.422

2.  Limited cross-species transmission and absence of mutations associated with SARS-CoV-2 adaptation in cats: A case study of infection in a small household setting.

Authors:  Serafeim C Chaintoutis; Victoria I Siarkou; Mathios E Mylonakis; George M Kazakos; Panagiota-Nefeli Skeva; Maria Bampali; Marios Dimitriou; Nikolaos Dovrolis; Zoe S Polizopoulou; Ioannis Karakasiliotis; Chrysostomos I Dovas
Journal:  Transbound Emerg Dis       Date:  2021-05-16       Impact factor: 4.521

3.  Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.

Authors:  Isabel Brand; Leonard Gilberg; Jan Bruger; Mercè Garí; Andreas Wieser; Tabea M Eser; Jonathan Frese; Mohamed I M Ahmed; Raquel Rubio-Acero; Jessica M Guggenbuehl Noller; Noemi Castelletti; Jana Diekmannshemke; Sophie Thiesbrummel; Duc Huynh; Simon Winter; Inge Kroidl; Christiane Fuchs; Michael Hoelscher; Julia Roider; Sebastian Kobold; Michael Pritsch; Christof Geldmacher
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

4.  Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity.

Authors:  Hengsheng Fang; Adam D Wegman; Kianna Ripich; Heather Friberg; Jeffrey R Currier; Stephen J Thomas; Timothy P Endy; Adam T Waickman
Journal:  Viruses       Date:  2021-05-15       Impact factor: 5.048

5.  Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.

Authors:  Elżbieta Kalicińska; Donata Szymczak; Aleksander Zińczuk; Barbara Adamik; Jakub Smiechowicz; Tomasz Skalec; Danuta Nowicka-Suszko; Monika Biernat; Aleksandra Bogucka-Fedorczuk; Justyna Rybka; Adrian Martuszewski; Waldemar Gozdzik; Krzysztof Simon; Tomasz Wróbel
Journal:  Cells       Date:  2021-05-23       Impact factor: 6.600

6.  Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.

Authors:  Niklas Bobrovitz; Rahul Krishan Arora; Christian Cao; Emily Boucher; Michael Liu; Claire Donnici; Mercedes Yanes-Lane; Mairead Whelan; Sara Perlman-Arrow; Judy Chen; Hannah Rahim; Natasha Ilincic; Mitchell Segal; Nathan Duarte; Jordan Van Wyk; Tingting Yan; Austin Atmaja; Simona Rocco; Abel Joseph; Lucas Penny; David A Clifton; Tyler Williamson; Cedric P Yansouni; Timothy Grant Evans; Jonathan Chevrier; Jesse Papenburg; Matthew P Cheng
Journal:  PLoS One       Date:  2021-06-23       Impact factor: 3.240

7.  Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection.

Authors:  Marc Scherlinger; Renaud Felten; Floriane Gallais; Charlotte Nazon; Emmanuel Chatelus; Luc Pijnenburg; Amaury Mengin; Adrien Gras; Pierre Vidailhet; Rachel Arnould-Michel; Sabrina Bibi-Triki; Raphaël Carapito; Sophie Trouillet-Assant; Magali Perret; Alexandre Belot; Seiamak Bahram; Laurent Arnaud; Jacques-Eric Gottenberg; Samira Fafi-Kremer; Jean Sibilia
Journal:  Infect Dis Ther       Date:  2021-07-10

8.  Field and Molecular Epidemiology: How Viral Sequencing Changed Transmission Inferences in the First Portuguese SARS-CoV-2 Infection Cluster.

Authors:  Nicole Pedro; Veronica Fernandes; Bruno Cavadas; João Tiago Guimarães; Henrique Barros; Margarida Tavares; Luisa Pereira
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

9.  Decline in neutralising antibody responses, but sustained T-cell immunity, in COVID-19 patients at 7 months post-infection.

Authors:  Jun Chen; Xiaomin Liu; Xinyu Zhang; Yixiao Lin; Danping Liu; Jingna Xun; Zhenyan Wang; Ling Gu; Qian Li; Dan Yin; Junyang Yang; Hongzhou Lu
Journal:  Clin Transl Immunology       Date:  2021-07-26

10.  Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.

Authors:  Marta Massanella; Anabel Martin-Urda; Lourdes Mateu; Toni Marín; Irene Aldas; Eva Riveira-Muñoz; Athina Kipelainen; Esther Jiménez-Moyano; Maria Luisa Rodriguez de la Concepción; Carlos Avila-Nieto; Benjamin Trinité; Edwards Pradenas; Jordi Rodon; Silvia Marfil; Mariona Parera; Jorge Carrillo; Julià Blanco; Julia G Prado; Ester Ballana; Júlia Vergara-Alert; Joaquim Segalés; Marc Noguera-Julian; Àngels Masabeu; Bonaventura Clotet; Maria de la Roca Toda; Roger Paredes
Journal:  Open Forum Infect Dis       Date:  2021-06-23       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.